← 產業報告目錄
In Vitro Diagnostic (IVD) Reagents Market Size, Share & Trends Analysis Report By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others), By Use (Clinical Use, Research Use, Others), By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-27頁數 180報告編號 INSIGHTACE-b5ed10beec
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The In Vitro Diagnostic (IVD) Reagents Market on a global scale was estimated at USD 59.3 Bn in 2024 and is forecasted to attain USD 107.2 Bn by 2034, with a projected CAGR of 6.2% between 2025 and 2034.
At its core, In Vitro Diagnostic (IVD) Reagents pertains to crucial chemical compounds employed in laboratory analyses to examine samples obtained from the human body, such as blood, urine, and tissue. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
The market's upward path is supported by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global In Vitro Diagnostic (IVD) Reagents Market Snapshot
Chapter 4. Global In Vitro Diagnostic (IVD) Reagents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Antibodies
5.2.2. Purified Proteins and Peptides
5.2.3. Oligonucleotides
5.2.4. Others
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
6.2.1. Immunoassay
6.2.2. Clinical Chemistry
6.2.3. Molecular Diagnostics
6.2.4. Microbiology
6.2.5. Hematology
6.2.6. Others
Chapter 7. Market Segmentation 3: by Use Estimates & Trend Analysis
7.1. by Use & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Use:
7.2.1. Clinical Use
7.2.2. Research Use
7.2.3. Others
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:
8.2.1. IVD Manufacturers
8.2.2. Academic Institutes & Research Laboratories
8.2.3. Hospital Laboratories
8.2.4. Others
Chapter 9. In Vitro Diagnostic (IVD) Reagents Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.1.2. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.1.3. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.1.4. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.1.5. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.2. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.3. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.2.4. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.2.5. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.2. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.3. Asia-Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.3.4. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3.5. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.4.2. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.3. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.4.4. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4.5. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.5.2. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.3. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.5.4. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5.5. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc
10.2.2. Becton, Dickinson and Company
10.2.3. Bio-Rad Laboratories, Inc
10.2.4. Agilent Technologies, Inc.
10.2.5. QIAGEN N.V.
10.2.6. Merck KGaA
10.2.7. Beckman Coulter, Inc
10.2.8. Hologic, Inc
10.2.9. Abcam Ltd
10.2.10. Bio-Techne Corp
10.2.11. InBios International, Inc.
10.2.12. SDIX, LLC
10.2.13. RayBiotech, Inc.
10.2.14. Sino Biological Inc.
10.2.15. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們